Virios Therapeutics VIRI has initiated patient dosing in its exploratory Long-COVID trial evaluating IMC-2 (valacyclovir + celecoxib). IMC-2 is an antiviral therapy combining valacyclovir and ...

Please provide your email address to receive an email when new articles are posted on . Herpes simplex encephalitis (HSE) is likely the most serious herpes infection patients can face. Treatment ...